Article
The potential of the human osteopontin promoter and single-nucleotide polymorphisms for targeted cancer gene therapy.
Current gene therapy - 1 Jan 2015
Chen X G, Godbey W T
Abstract excerpt
Regulatory elements of the osteopontin (opn) gene are attractive candidates for expressiontargeted gene therapy because numerous malignant cancers are marked by opn overexpression. The maximum opn promoter ((P)opn)-driven reporter intensity obtained for tested cancer cell lines was as strong (102.69%) as positive-control transfections. At the same time, (P)opn-driven reporter expression was reduced by ~90% in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
